CD4 and type 1 diabetes mellitus: An increase was observed for the percentages of CD4+ Teff PD1+, CD4+ Teff PD1 low and CD4+ Teff PD1high cells of type 1 diabetes PBMC, post Pep3 administration, in respect to untreated cells (Fig 6d–6f).